Mepolizumab-Related Blood Eosinophil Decreases Are Associated with Clinical Remission in Severe Asthmatic Patients: A Real-World Study
<b>Background</b>: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear. <b>Objective</b>: The aim of this study was to assess the relationship between mepolizumab-induced blood eosino...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2025-07-01
|
| Ráidu: | Antibodies |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2073-4468/14/3/61 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|